Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Collier, AC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 77 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Eisenbud, R; Assmann, SF; Kalish, LA; van der Horst, C; Collier, AC
      Differences difficulty adjudicating clinical events in patients with advanced HIV disease

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Para, MF; Kalish, LA; Collier, AC; Pollard, RB; Kumar, PN; Mintz, L; Wallach, FR; Drew, WL
      Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Murphy, EL; Assmann, SF; Collier, AC; Flanigan, TP; Kumar, PN; Wallach, FR; Krubel, S
      Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998

      CLINICAL INFECTIOUS DISEASES
    4. Arduino, JM; Fischl, MA; Stanley, K; Collier, AC; Spiegelman, D
      Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    5. Havlir, DV; Gilbert, PB; Bennett, K; Collier, AC; Hirsch, MS; Tebas, P; Adams, EM; Wheat, LJ; Goodwin, D; Schnittman, S; Holohan, MK; Richman, DD
      Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression

      AIDS
    6. Havlir, DV; Bassett, R; Levitan, D; Gilbert, P; Tebas, P; Collier, AC; Hirsch, MS; Ignacio, C; Condra, J; Gunthard, HF; Richman, DD; Wong, JK
      Prevalence and predictive value of intermittent viremia with combination HIV therapy

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    7. Collier, AC; Kalish, LA; Busch, MP; Gernsheimer, T; Assmann, SF; Lane, TA; Asmuth, DM; Lederman, MM; Murphy, EL; Kumar, P; Kelley, M; Flanigan, TP; McMahon, DK; Sacks, HS; Kennedy, MS; Holland, PV
      Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection - The viral activation transfusion study: A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    8. Seth, A; Markee, J; Hoering, A; Sevin, A; Sabath, DE; Schmitz, RE; Kuroda, MJ; Lifton, MA; Hirsch, MS; Collier, AC; Letvin, NL; McElrath, J
      Alterations in T cell phenotype and human immunodeficiency virus type 1 - Specific cytotoxicity after potent antiretroviral therapy

      JOURNAL OF INFECTIOUS DISEASES
    9. Para, MF; Kalish, LA; Collier, AC; Murphy, EL; Drew, WL
      Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion

      JOURNAL OF INFECTIOUS DISEASES
    10. Berrey, MM; Schacker, T; Collier, AC; Shea, T; Brodie, SJ; Mayers, D; Coombs, R; Krieger, J; Chun, TW; Fauci, A; Self, SG; Corey, L
      Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS

      JOURNAL OF INFECTIOUS DISEASES
    11. Curtis, JR; Patrick, DL; Caldwell, ES; Collier, AC
      Abuse of futility - Reply

      ARCHIVES OF INTERNAL MEDICINE
    12. Murphy, EL; Collier, AC; Kalish, LA; Assmann, SF; Para, MF; Flanigan, TP; Kumar, PN; Mintz, L; Wallach, FR; Nemo, GJ
      Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease

      ANNALS OF INTERNAL MEDICINE
    13. Boutin, PD; Buchwald, D; Robinson, L; Collier, AC
      Use of and attitudes about alternative and complementary therapies among outpatients and physicians at a municipal hospital

      JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
    14. Vanhems, P; Hughes, J; Collier, AC; Vizzard, J; Perrin, L; Cooper, DA; Hirschel, B; Corey, L
      Comparison of clinical features, CD4 and CD8 responses among patients withacute HIV-1 infection from Geneva, Seattle and Sydney

      AIDS
    15. Zhou, XJ; Havlir, DV; Richman, DD; Acosta, EP; Hirsch, M; Collier, AC; Tebas, P; Sommadossi, JP
      Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients

      AIDS
    16. Haas, DW; Arathoon, E; Thompson, MA; Pedro, RD; Gallant, JE; Uip, DE; Currier, J; Noriega, LM; Lewi, DS; Uribe, P; Benetucci, J; Cahn, P; Paar, D; White, CA; Collier, AC; Ramirez-Ronda, CH; Harvey, C; Chung, M; Mehrotra, D; Chodakewitz, J; Nguyen, BY
      Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine

      AIDS
    17. Ioannidis, JPA; Havlir, DV; Tebas, P; Hirsch, MS; Collier, AC; Richman, DD
      Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication

      AIDS
    18. Havlir, DV; Hellmann, NS; Petropoulos, CJ; Whitcomb, JM; Collier, AC; Hirsch, MS; Tebas, P; Sommadossi, JP; Richman, DD
      Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    19. Collier, AC; Tingle, MD; Keelan, JA; Paxton, JW; Mitchell, MD
      A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines

      DRUG METABOLISM AND DISPOSITION
    20. Para, MF; Glidden, DV; Coombs, RW; Collier, AC; Condra, JH; Craig, C; Bassett, R; Leavitt, R; Snyder, S; McAuliffe, V; Boucher, C
      Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS Clinical Trials Group protocol 333

      JOURNAL OF INFECTIOUS DISEASES
    21. Kalish, LA; Collier, AC; Flanigan, TP; Kumar, PN
      Plasma human immunodeficiency virus (HIV) type 1 RNA load in men and womenwith advanced HIV-1 disease

      JOURNAL OF INFECTIOUS DISEASES
    22. Curtis, JR; Patrick, DL; Caldwell, ES; Collier, AC
      The attitudes of patients with advanced AIDS toward use of the medical futility rationale in decisions to forgo mechanical ventilation

      ARCHIVES OF INTERNAL MEDICINE
    23. Curtis, JR; Patrick, DL; Caldwell, ES; Collier, AC
      Why don't patients and physicians talk about end-of-life care? Barriers tocommunication for patients with acquired immunodeficiency syndrome and their primary care clinicians

      ARCHIVES OF INTERNAL MEDICINE
    24. Revicki, DA; Swartz, C; Wu, AW; Haubrich, R; Collier, AC
      Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm(3)

      ANTIVIRAL THERAPY
    25. Curtis, JR; Patrick, DL; Caldwell, E; Greenlee, H; Collier, AC
      The quality of patient-doctor communication about end-of-life care: a study of patients with advanced AIDS and their primary care clinicians

      AIDS
    26. Brambilla, D; Reichelderfer, PS; Bremer, JW; Shapiro, DE; Hershow, RC; Katzenstein, DA; Hammer, SM; Jackson, B; Collier, AC; Sperling, RS; Fowler, MG; Coombs, RW
      The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements

      AIDS
    27. Li, WZ; Coombs, RW; Collier, AC; Raisys, VA
      Determination of indinavir, a HIV-1 protease inhibitor, in human plasma using ion-pair reversed-phase high-performance liquid chromatography

      THERAPEUTIC DRUG MONITORING
    28. Schapiro, JM; Lawrence, J; Speck, R; Winters, MA; Efron, B; Coombs, RW; Collier, AC; Merigan, TC
      Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS Clinical Trials Group 229

      JOURNAL OF INFECTIOUS DISEASES
    29. Speck, CE; Coombs, RW; Koutsky, LA; Zeh, J; Ross, SO; Hooton, TM; Collier, AC; Corey, L; Cent, A; Dragavon, J; Lee, W; Johnson, EJ; Sampoleo, RR; Krieger, JN
      Risk factors for HIV-1 shedding in semen

      AMERICAN JOURNAL OF EPIDEMIOLOGY
    30. Collier, AC; Marra, CM; Sacks, LA
      Clinical manifestations of HIV infection and AIDS

      CLINICAL INFECTIOUS DISEASES
    31. COLLIER AC; SCHOENFELD D; HIRSCH M; VANDERHORST CM; DAVIS LG; STANLEY K; COREY L
      LACK OF EFFECT ON SURVIVAL OF HIGH-DOSE ACYCLOVIR AND ZIDOVUDINE COMPARED WITH ZIDOVUDINE ALONE FOR ACQUIRED-IMMUNODEFICIENCY-SYNDROME

      Antiviral therapy
    32. PANTHER LA; COOMBS RW; ZEH JE; COLLIER AC; COREY L
      UNINTEGRATED CIRCULAR HIV-1 DNA IN THE PERIPHERAL MONONUCLEAR-CELLS OF HIV-1-INFECTED SUBJECTS - ASSOCIATION WITH HIGH-LEVELS OF PLASMA HIV-1 RNA, RAPID DECLINE IN CD4 COUNT, AND CLINICAL PROGRESSION TO AIDS

      Journal of acquired immune deficiency syndromes and human retrovirology
    33. HAVLIR DV; MARSCHNER IC; HIRSCH MS; COLLIER AC; TEBAS P; BASSETT RL; IOANNIDIS JPA; HOLOHAN MK; LEAVITT R; BOONE G; RICHMAN DD
      MAINTENANCE ANTIRETROVIRAL THERAPIES IN HIV-INFECTED SUBJECTS WITH UNDETECTABLE PLASMA HIV RNA AFTER TRIPLE-DRUG THERAPY

      The New England journal of medicine
    34. MARRA CM; DUKES AC; COLLIER AC; REES TS; FADIC R; JOHNS DR
      THE ROLE OF ANTIRETROVIRALS IN THE PATHOGENESIS OF HEARING-LOSS IN HIV - PRELIMINARY FINDINGS

      Neurology
    35. Marra, CM; Boutin, P; Collier, AC
      Screening for distal sensory peripheral neuropathy in HIV-infected personsin research and clinical settings

      NEUROLOGY
    36. COOMBS RW; SPECK CE; HUGHES JP; LEE W; SAMPOLEO R; ROSS SO; DRAGAVON J; PETERSON G; HOOTEN TM; COLLIER AC; COREY L; KOUTSKY L; KRIEGER JN
      CULTURABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IN SEMEN - RELATIONSHIP TO HIV-1 RNA LOAD

      The Journal of urology
    37. IOANNIDIS JPA; COLLIER AC; COOPER DA; COREY L; FIDDIAN AP; GAZZARD BG; GRIFFITHS PD; CONTOPOULOSIOANNIDIS DG; LAU J; PAVIA AT; SAAG MS; SPRUANCE SL; YOULE MS
      CLINICAL EFFICACY OF HIGH-DOSE ACYCLOVIR IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A METAANALYSIS OF RANDOMIZED INDIVIDUAL PATIENT DATA

      The Journal of infectious diseases
    38. COONROD D; COLLIER AC; ASHLEY R; DEROUEN T; COREY L
      ASSOCIATION BETWEEN CYTOMEGALOVIRUS SEROCONVERSION AND UPPER GENITAL-TRACT INFECTION AMONG WOMEN ATTENDING A SEXUALLY-TRANSMITTED DISEASE CLINIC - A PROSPECTIVE-STUDY

      The Journal of infectious diseases
    39. COOMBS RW; SPECK CE; HUGHES JP; LEE W; SAMPOLEO R; ROSS SO; DRAGAVON J; PETERSON G; HOOTON TM; COLLIER AC; COREY L; KOUTSKY L; KRIEGER JN
      ASSOCIATION BETWEEN CULTURABLE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) IN SEMEN AND HIV-1 RNA LEVELS IN SEMEN AND BLOOD - EVIDENCE FOR COMPARTMENTALIZATION OF HIV-1 BETWEEN SEMEN AND BLOOD

      The Journal of infectious diseases
    40. MARSCHNER IC; COLLIER AC; COOMBS RW; DAQUILA RT; DEGRUTTOLA V; FISCHL MA; HAMMER SM; HUGHES MD; JOHNSON VA; KATZENSTEIN DA; RICHMAN DD; SMEATON LM; SPECTOR SA; SAAG MS
      USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY

      The Journal of infectious diseases
    41. GARDNER GC; PETRIN JH; COLLIER AC; PAAUW DS
      MYALGIAS, NON-RESTORATIVE SLEEP, AND FATIGUE IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS

      Journal of musculoskeletal pain
    42. VANHOVE GF; KASTRISSIOS H; GRIES JM; VEROTTA D; PARK KS; COLLIER AC; SQUIRES K; SHEINER LB; BLASCHKE TF
      PHARMACOKINETICS OF SAQUINAVIR, ZIDOVUDINE, AND ZALCITABINE IN COMBINATION THERAPY

      Antimicrobial agents and chemotherapy
    43. VANHOVE GF; GRIES JM; VEROTTA D; SHEINER LB; COOMBS R; COLLIER AC; BLASCHKE TF
      EXPOSURE-RESPONSE RELATIONSHIPS FOR SAQUINAVIR, ZIDOVUDINE, AND ZALCITABINE IN COMBINATION THERAPY

      Antimicrobial agents and chemotherapy
    44. CURTIS JR; ULLMAN M; COLLIER AC; KRONE MR; EDLIN BR; BENNETT CL
      VARIATIONS IN MEDICAL-CARE FOR HIV-RELATED PNEUMOCYSTIS-CARINII PNEUMONIA - A COMPARISON OF PROCESS AND OUTCOME AT 2 HOSPITALS

      Chest
    45. SCHACKER T; COLLIER AC; HUGHES J; SHEA T; COREY L
      CLINICAL-FEATURES OF HIV-INFECTION (VOL 125, PG 257, 1996)

      Annals of internal medicine
    46. COLLIER AC; COOMBS RW; SCHOENFELD DA; BASSETT R; BARUCH A; COREY L
      COMBINATION THERAPY WITH ZIDOVUDINE, DIDANOSINE AND SAQUINAVIR

      Antiviral research
    47. BUCHWALD D; COLLIER AC; LUKEHART SA; KITH P; GOLDSTEIN E; HOOTON TM
      EVALUATION OF CEREBROSPINAL-FLUID IN SOUTHEAST-ASIAN REFUGEES WITH REACTIVE SEROLOGIC TESTS FOR SYPHILIS

      Western journal of medicine
    48. COLLIER AC; COOMBS RW; SCHOENFELD DA; BASSETT RL; TIMPONE J; BARUCH A; JONES M; FACEY K; WHITACRE C; MCAULIFFE VJ; FRIEDMAN HM; MERIGAN TC; REICHMAN RC; HOOPER C; COREY L
      TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION WITH SAQUINAVIR, ZIDOVUDINE, AND ZALCITABINE

      The New England journal of medicine
    49. SCHACKER T; COLLIER AC; HUGHES J; SHEA T; COREY L
      CLINICAL AND EPIDEMIOLOGIC FEATURES OF PRIMARY HIV-INFECTION

      Annals of internal medicine
    50. SCHACKER T; COLLIER AC; COOMBS R; UNADKAT JD; FOX I; ALAM J; WANG JP; EGGERT E; COREY L
      PHASE-I STUDY OF HIGH-DOSE, INTRAVENOUS RSCD4 IN SUBJECTS WITH ADVANCED HIV-1 INFECTION

      Journal of acquired immune deficiency syndromes and human retrovirology
    51. COLLIER AC; COOMBS RW; KATZENSTEIN D; HOLODNIY M; GIBSON J; MORDENTI J; IZU AE; DULIEGE AM; AMMANN AJ; MERIGAN T; COREY L
      SAFETY, PHARMACOKINETICS, AND ANTIVIRAL RESPONSE OF CD4-IMMUNOGLOBULIN-G BY INTRAVENOUS BOLUS IN AIDS AND AIDS-RELATED COMPLEX

      Journal of acquired immune deficiency syndromes and human retrovirology
    52. JACOBSON MA; DEGRUTTOLA V; REDDY M; ARDUINO JM; STRICKLAND S; REICHMAN RC; BARTLETT JA; PHAIR JP; HIRSCH MS; COLLIER AC; SOEIRO R; VOLBERDING P
      THE PREDICTIVE VALUE OF CHANGES IN SEROLOGIC AND CELL MARKERS OF HIV ACTIVITY FOR SUBSEQUENT CLINICAL OUTCOME IN PATIENTS WITH ASYMPTOMATICHIV DISEASE TREATED WITH ZIDOVUDINE

      AIDS
    53. CUNDY KC; BARDITCHCROVO P; WALKER RE; COLLIER AC; EBELING D; TOOLE J; JAFFE HS
      CLINICAL PHARMACOKINETICS OF ADEFOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUSTYPE 1-INFECTED PATIENTS

      Antimicrobial agents and chemotherapy
    54. VOLBERDING PA; LAGAKOS SW; GRIMES JM; STEIN DS; ROONEY J; MENG TC; FISCHL MA; COLLIER AC; PHAIR JP; HIRSCH MS; HARDY WD; BALFOUR HH; REICHMAN RC
      A COMPARISON OF IMMEDIATE WITH DEFERRED ZIDOVUDINE THERAPY FOR ASYMPTOMATIC HIV-INFECTED ADULTS WITH CD4 CELL COUNTS OF 500 OR MORE PER CUBIC MILLIMETER

      The New England journal of medicine
    55. KRIEGER JN; COOMBS RW; COLLIER AC; HO DD; ROSS SO; ZEH JE; COREY L
      INTERMITTENT SHEDDING OF HUMAN-IMMUNODEFICIENCY-VIRUS IN SEMEN - IMPLICATIONS FOR SEXUAL TRANSMISSION

      The Journal of urology
    56. KRIEGER JN; COOMBS RW; COLLIER AC; ROSS SO; SPECK C; COREY L
      SEMINAL SHEDDING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND HUMAN CYTOMEGALOVIRUS - EVIDENCE FOR DIFFERENT IMMUNOLOGICAL CONTROLS

      The Journal of infectious diseases
    57. COLLIER AC; HANDSFIELD HH; ASHLEY R; ROBERTS PL; DEROUEN T; MEYERS JD; COREY L
      CERVICAL BUT NOT URINARY-EXCRETION OF CYTOMEGALOVIRUS IS RELATED TO SEXUAL-ACTIVITY AND CONTRACEPTIVE PRACTICES IN SEXUALLY ACTIVE WOMEN

      The Journal of infectious diseases
    58. RAGNI MV; LOFARO ML; DEGRUTTOLA V; VANDERHORST C; EYSTER ME; KESSLER CM; GJERSET GF; HO M; PARENTI DM; DAFNI U; RASHEED S; KORVICK JA; MERIGAN TC; FISCUS S; GUPTA P; KATZMAN M; SHAFER R; MEYER WS; COOMBS RW; LANDRY BS; KASDAN P; NERHOOD L; STOWELL R; KAZIAL K; BROWNSTEIN A; KRAMER AS; WASSERMAN S; BLOODGOOD K; MCMAHON D; SUPERDOCK B; ISRAELSKI DM; CAIN P; CARFAGNA E; QUINLAN C; HAWLEY P; LELACHEUR SF; MUENCH L; COLLIER AC; CHENG L; LI XY; MORSE G
      RANDOMIZED STUDY OF DIDANOSINE MONOTHERAPY AND COMBINATION THERAPY WITH ZIDOVUDINE IN HEMOPHILIC AND NONHEMOPHILIC SUBJECTS WITH ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION

      Blood
    59. MARRA CM; CRITCHLOW CW; HOOK EW; COLLIER AC; LUKEHART SA
      CEREBROSPINAL-FLUID TREPONEMAL ANTIBODIES IN UNTREATED EARLY SYPHILIS

      Archives of neurology
    60. DOLIN R; AMATO DA; FISCHL MA; PETTINELLI C; BELTANGADY M; LIOU SH; BROWN MJ; CROSS AP; HIRSCH MS; HARDY WD; MILDVAN D; BLAIR DC; POWDERLY WG; PARA MF; FIFE KH; STEIGBIGEL RT; SMALDONE L; CRUMPACKER CS; COOLEY T; MITSUYASO RT; JOHN R; SANDERS C; REITMAN D; HEWITT R; REICHMAN RC; GELB LD; MCGUIRE ML; JONES M; NEIDIG JL; ZWICKL B; HARTMAN PB; ROARKE ME; BURK RA; FUHRER J; SOMOGYI KA; SEPKOWITZ K; TELZAK EE; MCAULIFFE VJ; VALENTINE FT; VASQUEZ M; MERIGAN TC; KATZENSTEIN D; FESSELL J; HAVLIR DV; RICHMAN DD; SPECTOR SA; KAHN JO; JOHNSON L; COLEMAN R; HO M; MCMAHON D; PAZIN G; ANTONISKIS D; MCNAMARA B; DIAMOND D; COLLIER AC; PARADISE MA; WALD A; DEPAOLISJONES A; HENRY K; WASKIN HA; HYSLOP NE; MUSHATT DM; ZACHARY JA; SOEIRO R; HARRIS C; ZINGMAN B; GIORDANO MF; SLEDZ S; MURRAY HW; CAREY JT; DAVIS TL; BAGBY B; KESSLER HA; MURPHY RL; HIRSCHTICK RE; CHEESEMAN SH; LAI KK; FAIRCHILD PG; EHMANN WC; ZURLO JJ; MILLARD R; TROIANI L; HEGGEN AA; VANDERHORST CM; MCKINLEY GF; GRIECO MH; KOLATCH BR; GOLDSMITH JC; GOMPERTS ED; WOODS LM; GRUE L; MAYJO K; BECKER RL; JAYAWEERA DT; ROLFE L; COLE J; JERMANO J
      ZIDOVUDINE COMPARED WITH DIDANOSINE IN PATIENTS WITH ADVANCED HIV TYPE-1 INFECTION AND LITTLE OR NO PREVIOUS EXPERIENCE WITH ZIDOVUDINE

      Archives of internal medicine
    61. FISCHL MA; STANLEY K; COLLIER AC
      AIDS CLINICAL-TRIALS GROUP-STUDY NUMBERS - RESPONSE

      Annals of internal medicine
    62. FISCHL MA; STANLEY K; COLLIER AC; ARDUINO JM; STEIN DS; FEINBERG JE; ALLAN JD; GOLDSMITH JC; POWDERLY WG; RAINES CP; MAYJO KJ; KERULY JC; CRAVEN D; HIRSHORN L; HIRSCH MS; JAYAWEERA DT; YOUNG SW; PATRONEREESE J; BRETTLER D; SPERBER K; GERITS P; SEREMETIS S; GILL JC; GELB LD; MCGUIRE ML; STIFFLER T; LEDERMAN MM; CAREY JT; WALLACE M; MACARTHUR RD; BERGE P; MILDVAN D; COREY L; COOMBS RW; CUMMINGS DK; SCHOOLEY RT; RAY MG; WAITE V; KURITZKES DR; FUHRER J; TENZLER RJ; DONLON W; VANDERHORST CM; TROIANI L; HORTON J; LANE TW; MURPHY RR; PHAIR JP; KESSLER HA; BENSON CA; ROSENWALD V; YONREN S; VALENTINE F; HASLETT P; MITSUYASU RT; GUERRO M; GOETZ MB; MATHISEN GE; FRAME PT; BRINKDOPKE J; POWELL T; HOELLE M; MERIGAN TC; SHAFER R; CAIN P; FESSELL J; HENRY K; RHAME F; CHRISTENSON J; STRYKE D; ZINGMAN B; KAHL P; SOEIRO R; CHOI YS; REICHMAN RL; REID J; BLAIR DC; STEIGBIGEL RT; HEWITT RG; CAMERON ML; DONNELLY MA; PACKARD MV; BARTLETT JA; FIFE KH; ZWICKL BW; BORUM J; BURACK JH; DYBECK KA; COLEMAN RL; JOHNSON WR; MCKINLEY GF; GRIECO MH; KOLATCH BR; SEPKOWITZ K; PONTICELLO L; GIORDANO MF; MURRAY HW; GOCKE DJ; FASS RJ; PARA MF; STERN JS; DREW LJ; SPECTOR SA; HAVLIR DV; NUFFER KL; RICHMAN DD; CONNOR EM; KLOSER PC; PICARDI JM; VANMATERMINER C; LEEDOM JM; HOLTOM PD; RICHARDSON W; EHMANN WC; ZURLO JJ; KREHER M; EYSTER ME; HYSLOP NE; MUSHATT DM; HOADLEY DJ; ZACHARY JA; SIMON GL; PARENTI DM; LELACHEUR S; SCHUCK S; HO MT; MCMAHON DK; PAZIN GJ; ROSENER R; CHEESEMAN SH; MANGINI LA; SANDS MG; KAZIAL K; JONES G; PETTINELLI CB; LANDRY B; MARTINEZ AI
      COMBINATION AND MONOTHERAPY WITH ZIDOVUDINE AND ZALCITABINE IN PATIENTS WITH ADVANCED HIV DISEASE

      Annals of internal medicine
    63. CURTIS JR; GREENBERG DL; HUDSON LD; FISHER LD; KRONE MR; COLLIER AC
      CHANGING USE OF INTENSIVE-CARE FOR HIV-INFECTED PATIENTS WITH PNEUMOCYSTIS-CARINII PNEUMONIA

      American journal of respiratory and critical care medicine
    64. FISCHL MA; RESNICK L; COOMBS R; KREMER AB; POTTAGE JC; FASS SJ; FIFE KH; POWDERLY WG; COLLIER AC; ASPINALL RL; SMITH SL; KOWALSKI KG; WALLEMARK CB
      THE SAFETY AND EFFICACY OF COMBINATION N-BUTYL-DEOXYNOJIRIMYCIN (SC-48334) AND ZIDOVUDINE IN PATIENTS WITH HIV-1 INFECTION AND 200-500 CD4 CELLS MM(3)/

      Journal of acquired immune deficiency syndromes
    65. COLLIER AC
      EARLY INTERVENTION IN HIV-INFECTION - WHERE ARE WE

      AIDS patient care
    66. COLLIER AC
      EARLY INTERVENTION IN HIV-INFECTION - WHERE ARE WE

      AIDS research and human retroviruses
    67. JACOBSON MA; WULFSOHN M; FEINBERG JE; DAVIS R; POWER M; OWENS S; CAUSEY D; HEATHCHIOZZI ME; MURPHY RL; CHEUNG TW; DIETERICH DT; SPECTOR SA; MCKINLEY GF; PARENTI DM; CRUMPACKER C; NISHIMOTO B; LEEDOM JM; KRAMER F; COHEN C; LOFTUS J; KESSLER HA; POTTAGE JC; BENSON CA; PHAIR JP; GERITS P; CHUSID E; SACKS HS; FRIEDBERG D; CURRANKRIKORIAN K; VALENTINE FT; MENG TC; FREEMAN WR; MEIXNER L; RICHMAN D; ODONNELL JJ; KIMBRELL C; BOGGIO K; LARSON J; WHITMORE PV; SIMON GL; LELACHEUR S; FIFE K; ZWICKL B; RELUE J; STEIGBIGEL RT; FUHRER J; DONLON W; BURK RA; PORTMORE AC; WEISSBACH NE; HOOTON TM; HOLZWORTH P; DAVISON S; COLLIER AC; POWDERLY WG; KLEBERT M; ROYAL M; SEYFRIED W; SQUIRES KC; WEISS W; BARBACCI M; BECKER RL; JABS D; BARTLETT JG; PARA MF; JONES M; NEIDIG JL; FASS RJ; VANDERHORST C; KYLSTRA J; RAASCH R; BLOODGOOD K; WOLITZ R; KIRK S; ROLFE L; PATRONEREESE J; BARTLETT JA; WASKIN HA; WILLIAMS DK; SHIP KW; KAHL P; ASSAYKEEN T; KAROL C; MARTINMUNLEY S; SUMNER P
      PHASE-II DOSE-RANGING TRIAL OF FOSCARNET SALVAGE THERAPY FOR CYTOMEGALOVIRUS RETINITIS IN AIDS PATIENTS INTOLERANT OF OR RESISTANT TO GANCICLOVIR (ACTG PROTOCOL 093)

      AIDS
    68. COLLIER AC
      NEW DIRECTIONS FOR ACTG

      Lancet
    69. FLETCHER CV; COLLIER AC; RHAME FS; BENNETT D; PARA MF; BEATTY CC; JONES CE; BALFOUR HH
      FOSCARNET FOR SUPPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION

      Antimicrobial agents and chemotherapy
    70. STANLEY KE; FISCHL MA; COLLIER AC
      CLINICAL-TRIALS - SUBGROUP ANALYSES

      Science
    71. KENNEDY S; COLLIER AC
      STRESS-INDUCED MODULATION OF THE IMMUNE-RESPONSE IN THE DEVELOPING RAT PUP

      Physiology & behavior
    72. MARRA CM; BOUTIN P; ROBINSON LR; COLLIER AC
      UNRECOGNIZED DISTAL SENSORY NEUROPATHY (DSPN) IN HIV - CONTRIBUTION OF ANTIRETROVIRAL THERAPY

      Neurology
    73. FAIRFAX MR; SCHACKER T; CONE RW; COLLIER AC; COREY L
      HUMAN HERPESVIRUS-6 DNA IN BLOOD-CELLS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED MEN - CORRELATION OF HIGH-LEVELS WITH HIGH CD4 CELL COUNTS

      The Journal of infectious diseases
    74. SCHACKER T; COOMBS RW; COLLIER AC; ZEH JE; FOX I; ALAM J; NELSON K; EGGERT E; COREY L
      THE EFFECTS OF HIGH-DOSE RECOMBINANT SOLUBLE CD4 ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIREMIA

      The Journal of infectious diseases
    75. MARRA CM; LONGSTRETH WT; COLLIER AC; MAXWELL CL; HANDSFIELD HH
      PROSPECTIVE-STUDY OF NEUROLOGIC INVOLVEMENT IN HIV-INFECTION WITHOUT AIDS - 2-YEAR FOLLOW-UP

      Neurology
    76. COLLIER AC; COOMBS RW; FISCHL MA; SKOLNIK PR; NORTHFELT D; BOUTIN P; HOOPER CJ; KAPLAN LD; VOLBERDING PA; DAVIS LG; HENRARD DR; WELLER S; COREY L
      COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE COMPARED WITH ZIDOVUDINE ALONE IN HIV-1 INFECTION

      Annals of internal medicine
    77. CURTIS JR; GREENBERG DL; FISHER LD; KRONE MR; HUDSON LD; COLLIER AC
      TRENDS IN SURVIVAL RATES AND INTUBATION RATES FOR HIV-INFECTED PATIENTS WITH PNEUMOCYSTIS PNEUMONIA

      The American review of respiratory disease


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 09:04:46